INTAS DRHP PDF

Read more about Intas Pharma files draft prospectus for IPO on Business Standard. Drug maker Intas Pharmaceuticals today said it has filed. Intas Pharmaceuticals, has filed its draft red herring prospectus (DRHP) with Securities and Exchange Board of India (SEBI) for an initial public. Intas Pharma DRHP News: Latest and Breaking News on Intas Pharma DRHP. Explore Intas Pharma DRHP profile at Times of India for photos, videos and latest .

Author: Zolosho Kigabei
Country: Russian Federation
Language: English (Spanish)
Genre: Science
Published (Last): 8 July 2018
Pages: 414
PDF File Size: 4.75 Mb
ePub File Size: 14.3 Mb
ISBN: 171-8-49215-980-9
Downloads: 93635
Price: Free* [*Free Regsitration Required]
Uploader: Voodoolkis

At present, domestic companies are marketing their products only in emerging markets, but the largest and most lucrative market for all pharmaceuticals — the US — is the next stop. Intas Pharma files for an IPO.

The IPO will be made through a public issue of equity shares of face value of Rs.

Intas Pharma files for an IPO

Sources said the group has started a process to sell drug discovery services company Advinus Therapeutics, drawing interest from private equity funds Kedaara Capital and True North as well as from strategic players, GVK Biosciences and Lambda, a unit of Intas Pharma. Intaw Our Digital Magazine: Web Interface Conceived and Powered By: Intas Pharma buys Spanish company’s hospital business. Its products are marketed in over 60 countries, either directly, through its subsidiaries or indirectly, through supply, distribution and other arrangements with various leading global ijtas companies.

Related Posts (10)  GENIUS LOCI CHRISTIAN NORBERG SCHULZ PDF

Intas to buy Teva’s UK, Ireland assets for mn pounds. Binish Hasmukh Chudgar, Mr. The Ahmedabad-based company is considering licensing agreements with hospital-based businesses in these markets.

Intas Pharma files draft prospectus for IPO

Rahul Gandhi listed as ‘non-Hindu’. Hyderabad-based pharma giant Aurobindo intxs up Portuguese co for Rs crore. All rights reserved Disclaimer. Monday, 31 December ChrysCap backs Curatio in latest pharma bet.

Intas Pharma launches first etanercept biosimilar. Medical Council of India MCI will investigate a complaint against 11 doctors from Madhya Pradesh who are charged with accepting foreign jaunts sponsored by pharmaceutical company. It is currently ranked as the 12th largest pharmaceutical company in the country with a 2. Intas Pharma drph group companies, subsidiaries. Intas Pharma eyes hospitals in Europe, US.

Mon, Dec 31, Updated Enquiry Thanks for inttas us! In what could further strengthen its business in European and non-European countries, Ahmedabad based Intas Pharmaceuticals Ltd has acquired hospital business of Combino Pharm in Spain and Portugal for an undisclosed sum.

We will get in touch with you shortly. Desi pharma companies top in drnp globally. According to sources, the company has begun the groundwork for the IPO and approached merchant bankers a couple of months ago.

Nimish Hasmukhbhai Chudgar, Dr. Chandra kicks off divestment plan. It has also extended its presence into other therapy areas such as gynecology, infertility, arthritis and the respiratory.

Intas Pharmaceuticals files DRHP for IPO

From around the Web. Subscribe to BioSpectrum India.

Related Posts (10)  ASSIGNATION TEMPORAIRE CSST PDF

Please fill the all fields. The promoters of the company are Mr. Please note that comments are moderated and are generally published if they are on-topic and not abusive. The company is present in various major therapy areas such as those relating to neurology, psychiatry, cardiology, pain management, gastroenterology, diabetology, nephrology, urology, anti-infective therapy, dermatology, gynecology, respiratory system, oncology, critical care and ophthalmology with a strong focus on chronic therapy areas relating to neurology, psychiatry, cardiology and diabetology.

Sun Pharma in early talks to buy Intas Pharma. Email Enter a valid email address. New Untas, May 26 RPG Life Sciences has sold its Gujarat-based biotechnology unit to Intas Pharmaceuticals for Rs 25 crore to focus on core areas of business and improve long-term competitiveness in a rapidly changing market. Please click here to Sign-in or Sign-up.

Drug-maker Intas Pharmaceuticals has merged all its group companies and subsidiaries over itas about low profits. Drugs sold sans regulator’s nod, safety studies. Intas Pharma is a vertically integrated Indian pharmaceutical company with global operations, engaged in the development, manufacture and marketing of pharmaceutical formulation. MCI to probe foreign jaunts by MP doctors.